Definitive Contract HHSN261201400038C
Award Date
9/15/14
Potential Completion Date
6/14/15
Potential Value
$223K
Federal Agency
National Cancer Institute
Awardee
Synergene Therapeutics Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20854, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
27
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a definitive contract awarded by the National Cancer Institute, a civilian agency, to Synergos Incorporated on September 30, 2005. The contract, valued at $747,015.00, is for monitoring, data management, and statistical services for SS1P clinical trials. The contract does not have a set-aside designation and is a cost-no-fee contract type. The ultimate completion date for this contract is March 31, 2007.</p>
<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
This federal contract award, valued at $141,905.45, was issued by the National Cancer Institute (NCI) to the small business contractor Synergy Enterprises, Inc. The contract is for Task Order 5: Contract Management and Monitoring, and has an ultimate completion date of August 29, 2024. Synergy Enterprises is a minority-owned, woman-owned small business based in Rockville, Maryland that specializes in providing professional services to federal agencies, particularly in the areas of education,...
<p>This is a federal contract awarded by the National Cancer Institute, a civilian agency, to Transgenex Nanobiotech Inc., a minority-owned small business. The contract, valued at $224,999.00, is for a Small Business Innovation Research (SBIR) Program Phase I action. The contract is a definitive, firm-fixed-price contract with a completion date of September 15, 2015. This contract is set aside for small businesses.</p>
This is a federal contract award from the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract, worth $21,593,775.02, is for "PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND OTHER THERAPEUTIC AGENTS" and was awarded on December 15, 2004 with a completion date of December 14, 2012. The contract type is Definitive Contract with a Cost Plus Fixed Fee pricing...
<p>This is a $199,714.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency within the U.S. government, to String Therapeutics on September 20, 2012. The contract is for "OTHER FUNCTIONS - R & D BIOMEDICAL (BASIC RESEARCH)" and has a total small business set-aside. The contract has an ultimate completion date of June 19, 2013.</p>
<p>The National Cancer Institute, a civilian federal agency, awarded a $1,099,452.64 cost-plus-fixed-fee definitive contract to Zymera Inc., a self-certified small disadvantaged business, for a "HOMOGENEOUS NANO PARTICLE - BASED ASSAYS FOR PROTEASE DETECTION" research and development project under SBIR Phase II Topic No. 266. The contract was set aside for small businesses and has a completion date of June 24, 2015.</p>
This is a federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Pointcare Genomics Corp, a small minority-owned business, for research and development in biomedical basic research. The contract is a definitive, firm-fixed price contract valued at $299,961.00 and is part of the SBIR (Small Business Innovation Research) Program Phase I. The contract has a total small business set-aside designation and was awarded on September 22, 2015, with a completion date of...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
<p>This is a $779,879.76 definitive contract awarded by the National Cancer Institute, a civilian agency, to Cynvenio Biosystems, Inc., a small disadvantaged business. The contract is for research and development in the biomedical basic research domain and has a total small business set aside. The contract was awarded on September 20, 2013 and has a final completion date of September 19, 2015. The contract is a cost-no-fee type with a fixed-price pricing structure.</p>